Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 -0.02 (-5.09%)
As of: Oct 21, 2026 · 3:59 PM EDT

Citius Pharmaceuticals (CTXR) Finished Goods (2024 - 2026)

Updated

Citius Pharmaceuticals' Finished Goods was $15.67 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 0.2% from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Finished Goods (2024 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Finished Goods at Citius Pharmaceuticals came in at $10.58 million, up 72.4% from FY2024.

  • In earlier fiscal years, Finished Goods was $6.13 million in FY2024.
  • Quarterly Finished Goods has moved between $6.13 million (fiscal Q4 2024) and $15.71 million (fiscal Q2 2026) over five years.
  • Per Business Quant data, CTXR's Finished Goods in the three fiscal quarters before Q3 2026 was $15.71 million (Q2 2026), $15.69 million (Q1 2026) and $10.58 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Citius Pharmaceuticals 10.37 Mn -23.20 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.67 Mn
Mar 31, 2026 15.71 Mn
Dec 31, 2025 15.69 Mn
Sep 30, 2025 10.58 Mn
Sep 30, 2024 6.13 Mn
API Access

Citius Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=CTXR&period=max&api_key=YOUR_API_KEY